Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance
Conclusion
We confirmed that a drug exposure–efficacy association was found early on at induction. This study emphasizes that previous exposure to anti-TNFα and positive perinuclear antineutrophil cytoplasmic antibody serology are important factors influencing VDZ TLs at induction.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
More News: Gastroenterology | Inflammatory Bowel Disease | Lower Endoscopy | Remicade | Study | Ulcerative Colitis